HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life.
about
Pattern of Infectious Morbidity in HIV-Exposed Uninfected Infants and ChildrenClinical outcomes of HIV-exposed, HIV-uninfected children in sub-Saharan AfricaIncreased Risk of Group B Streptococcus Invasive Infection in HIV-Exposed but Uninfected Infants: A Review of the Evidence and Possible MechanismsThe Immune System of HIV-Exposed Uninfected InfantsLinking Susceptibility to Infectious Diseases to Immune System Abnormalities among HIV-Exposed Uninfected InfantsHIV-Exposed Uninfected Infants in Zimbabwe: Insights into Health Outcomes in the Pre-Antiretroviral Therapy Era.Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency.Salmonella enterica serovar Panama meningitis in exclusive breastfeeding infants: Report of 4 cases, clinical features and therapeutic challengesBreastfeeding is associated with decreased pneumonia incidence among HIV-exposed, uninfected Kenyan infantsEffectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and -uninfected children in south africa: a matched case-control study.Altered innate immune development in HIV-exposed uninfected infants.The role of environmental factors in modulating immune responses in early lifeFactors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort studyHigh-risk enteric pathogens associated with HIV infection and HIV exposure in Kenyan children with acute diarrhoeaIncreased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country.Skin, thermal and umbilical cord care practices for neonates in southern, rural Zambia: a qualitative study.Severe Infections in HIV-Exposed Uninfected Infants Born in a European CountryProportions of CD4+, CD8+ and B cell subsets are not affected by exposure to HIV or to Cotrimoxazole prophylaxis in Malawian HIV-uninfected but exposed children.Altered Memory T-Cell Responses to Bacillus Calmette-Guerin and Tetanus Toxoid Vaccination and Altered Cytokine Responses to Polyclonal Stimulation in HIV-Exposed Uninfected Kenyan InfantsAntibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life.Risk-taking behavior for HIV acquisition during pregnancy in Porto Alegre, Brazil.Breastfeeding Is Associated with Decreased Risk of Hospitalization among HIV-Exposed, Uninfected Kenyan InfantsNormal Thymic Size and Low Rate of Infections in Human Donor Milk Fed HIV-Exposed Uninfected Infants from Birth to 18 Months of Age.Delayed acquisition of Plasmodium falciparum antigen-specific CD4(+) T cell responses in HIV-exposed uninfected Malawian children receiving daily cotrimoxazole prophylaxisHematological Indices at Birth of Infants of HIV-Positive Mothers Participating in a Prevention of Mother-to-Child Transmission ProgramHIV-Exposed Uninfected Infants Show Robust Memory B-Cell Responses in Spite of a Delayed Accumulation of Memory B Cells: an Observational Study in the First 2 Years of Life.Malaria burden in a birth cohort of HIV-exposed uninfected Ugandan infants living in a high malaria transmission setting.Revisiting pneumonia and exposure status in infants born to HIV-infected mothers.A Prospective Cohort Study of Common Childhood Infections in South African HIV-exposed Uninfected and HIV-unexposed Infants.Maternal HIV infection influences the microbiome of HIV-uninfected infants.Cases of Impaired Oxidative Burst in HIV-Exposed Uninfected Infants' Neutrophils-A Pilot Study.Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial.HIV-exposed uninfected children: a growing population with a vulnerable immune system?Human rotavirus vaccine (Rotarix): focus on effectiveness and impact 6 years after first introduction in Africa.Child Growth According to Maternal and Child HIV Status in ZimbabweHigh Burden of Morbidity and Mortality but Not Growth Failure in Infants Exposed to but Uninfected with Human Immunodeficiency Virus in Tanzania.Perinatal HIV Infection and Exposure and their Association with Dental Caries in Nigerian Children.Protecting the health of our AIDS-free generation: beyond prevention of mother-to-child HIV transmission.Antibiotic resistance of Streptococcus pneumoniae colonising the nasopharynx of HIV-exposed Tanzanian infants.Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013.
P2860
Q26747400-3BC5F978-3BB1-429D-9526-60CB07F9ABD2Q26749153-5E032DFA-B81B-4F77-B346-94BC33B0E53AQ28067423-7B78999D-9752-4108-A527-62BA32D671C6Q28069872-15E98412-7700-468B-8954-5B91ED47F710Q28077904-DC92CE86-A9BB-41FB-8A63-DE5D171AFB4AQ30383065-8F5D0134-FED5-4F22-B6A8-BD442C6EA32BQ33624111-D73F6F32-7B77-4FBA-B756-8548B5A9D7B7Q33672472-0B2DEF57-3F96-4498-8771-DFCF87915700Q33854326-57F14FC8-2FFA-4629-B59E-FD3D2D21999EQ34087769-69DD3B1A-563F-4F38-B301-C565B2C19565Q34098338-3023C4AD-28D3-4950-8704-7EF49CA6FC4CQ34169396-2FC2553B-C1BB-47E9-9C2C-BF8E20327A1AQ34988296-60459DAC-18AC-48DE-B67F-F5E1C9ADB360Q35136908-643B2BD5-2E29-4F0E-B863-FE6131F68BF3Q35211424-4F27545C-8659-41E0-B292-69F18A6F5F20Q35692794-80CB3D38-9A31-40A9-8F20-12ABD2C9849EQ35748668-E350FDC4-0824-4A8E-89D7-61E860492B4CQ35758085-91924306-37FD-49C5-B89D-760CEA411ABEQ35841753-BD1F0AB8-4397-4F2F-96DB-4C7289BB3BB6Q36504806-8CFB0283-CA15-412D-9B5B-63F50E7D5685Q36515719-5E4D9A75-E8C6-4878-9E6C-D064C5986A3FQ36746559-85A1CD74-77F4-41F5-82EC-C504F506E76CQ36853673-C05E5853-99A4-48D2-BBA9-B089BD5F956BQ36886734-9462FCB7-CFA2-428A-B402-8648AB7A5F9FQ36967119-793AF0FD-331D-4C45-99AF-09D7382D5580Q37067271-486DDEA3-ACE3-423F-8260-1BEAFD85446EQ37350165-F28A0670-F040-46B3-9707-29D11730438EQ37405528-6F474F43-E26B-4F77-B1EB-D6218D2D7DF7Q37591893-AAC250BC-EB71-4B56-BB42-808102F8E4D7Q37635172-7CE00726-4CE9-4401-98F0-F26772A42D3EQ37689436-02AE1794-9234-4E39-8A61-BB4D3F073B5EQ37731612-7474650F-2C49-40D9-84C4-87096FCB7328Q38170189-4C93F92D-F714-4911-B090-3F74C8149B97Q38534245-6651F647-EFBB-49FB-A8B2-362422DBE2C2Q38960638-5B3FE8D8-9A2A-47FE-9991-DCA498A9AC0FQ40080607-01D211DD-92CF-4537-98BC-CB9D751D055DQ40107633-017B4BD4-C56A-4087-A4D6-7F6CD6914A5FQ40400569-34F39D48-3460-41DE-8E10-E1E87DABF65FQ41082335-61C90B7A-827F-43E6-BF37-295D9D5C6FBAQ41489687-C7AC9FD4-4F8B-4BAB-8C10-FA01A845461D
P2860
HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
HIV-exposed uninfected infants ...... ons in the first year of life.
@ast
HIV-exposed uninfected infants ...... ons in the first year of life.
@en
type
label
HIV-exposed uninfected infants ...... ons in the first year of life.
@ast
HIV-exposed uninfected infants ...... ons in the first year of life.
@en
prefLabel
HIV-exposed uninfected infants ...... ons in the first year of life.
@ast
HIV-exposed uninfected infants ...... ons in the first year of life.
@en
P2093
P2860
P356
P1476
HIV-exposed uninfected infants ...... ons in the first year of life.
@en
P2093
Amy Slogrove
Brian Reikie
Corena De Beer
David Speert
Mark Cotton
Monika Esser
Shalena Naidoo
P2860
P304
P356
10.1093/TROPEJ/FMS019
P577
2012-05-03T00:00:00Z